February 3, 2005
From basic discovery to breakthrough drug
'Determination and persistence' carries a controversial theory to development of drug that prevents inflammation, reduces MS relapse
By BARBARA BERG
There are few more satisfying experiences for scientists than to see their work benefit others. For Dr. Elizabeth Wayner, that gratification came last fall, when the U.S. Food and Drug Administration granted approval for a breakthrough drug to treat multiple sclerosis that is based ...